# Gerardo Jiménez Sánchez

Gerardo Jiménez Sánchez (born April 21, 1965) is a Mexican-born pediatrician, scientist, and businessman. Along with David Valle and Barton Childs, he completed the first medical analysis of the human genome. He founded and directed the first National Institute of Genomic Medicine in Latin America (INMEGEN), and led the team that developed the Genomic Map of the Mexican population.

## Biography

Jiménez Sánchez was born in Mexico City in 1965, the son of agricultural scientist Leobardo Jiménez and plant biochemist Estela Sánchez, both Mexican national emeritus investigators. He obtained a medical degree at the National Autonomous University of Mexico (UNAM) School of Medicine and completed his residency in pediatrics at the National Institute of Pediatrics. He earned a PhD in Human Genetics and Molecular Biology at Johns Hopkins University and pursued postgraduate training at Duke University. His postgraduate training included studies at Duke University. He specialized in Senior Business Management (AD2), Business on Innovation and Technology (ADIT), and Management Business by Services at the IPADE Business School.
He served as the President of the Working Party on Biotechnology at the Organisation for Economic Co-operation and Development (OECD) from 2006 to 2013. Currently, he is the President of the Committee on Genomics and Bioeconomy at the Human Genome Organization (HUGO), having been a member of its Board of Directors from 2007 to 2014. He also serves as the Executive President of the Global Biotech Consulting Group (GBC Group), where he focuses on genomic medicine, pharmacogenomics, and bio-based business development.
Jiménez-Sánchez is also Executive President of Medical Genomics, President of the Board of Directors at Genómica y Bioeconomía A.C., and Professor of Genomics and Bioeconomics at the School of Public Health at Harvard University. Along with Guillermo Soberón, Julio Frenk, Jorge Carpizo and Diego Valadés, he established Genómica y Bioeconomía A.C., a not-for-profit organization where he chairs the board. He was named Chief Scientific Officer for BioFields in 2010.
Jiménez-Sánchez was a member of the Advisory Board on Biotechnology to the Secretary-General of the United Nations, Kofi Annan, and President of the I and II National Congresses of Genomic Medicine in Mexico. In 2013, he presided over the International Forum “Genomics, Innovation, and Economic Growth”.
He was the first President of the Mexican Society of Genomic Medicine in Mexico in 2004. He received the Silanes Award in Genomic Medicine in 2003, and the Gold Master of the Top Management Forum chaired by King Juan Carlos I of Spain that same year. In 1997, he was inducted into the New York Academy of Sciences.
Jiménez-Sánchez is a member of the Mexican Society of Genomic Sciences (2004), the Mexican Pediatric Society (2000), the American Society of Gene Therapy (1999), the Latin American Society of Inborn Metabolic Errors (1998), the Society for Inherited Metabolic Disorders (1998), the American Society of Human Genetics (1997), the Latin American Society of Human Genetics (1990), the Society for the Study of Inborn Errors of Metabolism (1990), the Mexican Association of Human Genetics (1988), and the Mexican Society of Biochemistry (1986).
His work has been featured by Reforma.